$NXTD Monsanto’s public relations nightmare is music to the ears of those holding shares of Marrone Bio Innovations Inc. (NASDAQ: MBII). Marrone Bio Innovations provides pest management and plant health products for environmentally responsible and sustainable production in the agricultural and water treatment industries. With a market capitalization of $20.8 million, Marrone is making adjustments toward reaching profitability. Recent changes include appointing Nancy Hood, founder of Silverlake Consulting, as vice president of marketing. Another change involved the addition of Michael Benoff, former chief financial officer (CFO) of the Money Store, to Marrone's board of directors.Marrone's encouraging technical signals include an RSI emerging from a long stint in the oversold range and the advance of its MACD above the signal line. Expect to see some bullish trading action once this stock climbs to within 20% of its 50-day moving average after finding support at its Jan. 25 closing price of 85 cents per share. #Wocket
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.